Susan Ball - Publications, H-index & Citations

Susan Ball

Dermatologikum Hamburg

46H指数

214论文数

1.1W被引数

收录论文 43

发表时间

Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial

JAMA DERMATOLOGY

IF11

2024-10-01

OAAI

King, Brett; Ko, Justin; Kwon, Ohsang; Vano-Galvan, Sergio; Piraccini, Bianca Maria; Dutronc, Yves; Yu, Guanglei; Liu, Chunyuan; Somani, Najwa; Ball, Susan; Mesinkovska, Natasha A.

Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata 根据严重斑秃患者的头皮头发再生，Baricitinib治疗的临床益处

DERMATOLOGY AND THERAPY

IF4.2

2023-11-22

OAAI

Senna, Maryanne M.; Kwon, Ohsang; Piraccini, Bianca M.; Sinclair, Rodney; Ball, Susan; Ding, Yuxin; Chen, Yun-Fei; Dutronc, Yves; King, Brett

Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 Trials

JAMA DERMATOLOGY

IF11

2023-09-01

OAAI

Ko, Justin M.; Mayo, Tiffany T.; Bergfeld, Wilma F.; Dutronc, Yves; Yu, Guanglei; Ball, Susan G.; Somani, Najwa; Craiglow, Brittany G.

A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19 (vol 39, pg 4910, 2022)

ADVANCES IN THERAPY

IF4

2023-06-22

OAAI

Bieber, Thomas; Feist, Eugen; Irvine, Alan D. D.; Harigai, Masayoshi; Haladyj, Ewa; Ball, Susan; Deberdt, Walter; Issa, Maher; Grond, Susanne; Taylor, Peter C. C.

The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata

DERMATOLOGY AND THERAPY

IF4.2

2023-06-08

OAAI

Mesinkovska, Natasha; Craiglow, Brittany; Ball, Susan G.; Morrow, Paula; Smith, Sarah G.; Pierce, Evangeline; Shapiro, Jerry

Predictors of QOL in Patients with Alopecia Areata

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2022-10-01

OAAI

Senna, Maryanne; Ko, Justin; Glashofer, Marc; Walker, Chloe; Ball, Susan; Edson-Heredia, Emily; Zhu, Baojin; Shapiro, Jerry

A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19 Baricitinib在风湿病，皮肤病和新型冠状病毒肺炎的临床试验的安全性结果的回顾

ADVANCES IN THERAPY

IF4

2022-09-05

OAAI

Bieber, Thomas; Feist, Eugen; Irvine, Alan D.; Harigai, Masayoshi; Haladyj, Ewa; Ball, Susan; Deberdt, Walter; Issa, Maher; Grond, Susanne; Taylor, Peter C.

Improvement in symptoms of anxiety and depression in patients with atopic dermatitis after treatment with baricitinib

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2021-10-02

PREAI

Thyssen, J. P.; Lio, P.; Ball, S.; Pierce, E.; Sun, L.; Chen, Y.; Tan, J. K. L.; Augustin, M.

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2021-06-05

OAAI

Wollenberg, A.; Nakahara, T.; Maari, C.; Peris, K.; Lio, P.; Augustin, M.; Silverberg, J. I.; Rueda, M. J.; DeLozier, A. M.; Pierce, E.; Yang, F. E.; Sun, L.; Ball, S.; Tauber, M.; Paul, C.

Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2018-11-01

PREAI

Leonardi, Craig; Maari, Catherine; Philipp, Sandra; Goldblum, Orin; Zhang, Lu; Burkhardt, Nicole; Ball, Susan; Mallbris, Lotus; Gonzalez, Pablo; Fernandez-Penas, Pablo; Puig, Luis

Ixekizumab Pharmacokinetics, Anti-Drug Antibodies, and Efficacy through 60 Weeks of Treatment of Moderate to Severe Plaque Psoriasis

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2018-10-01

OAAI

Reich, Kristian; Jackson, Kimberley; Ball, Susan; Garces, Sandra; Kerr, Lisa; Chua, Laiyi; Muram, Talia M.; Blauvelt, Andrew

Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3)

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2018-02-23

OAAI

Papp, K. A.; Leonardi, C. L.; Blauvelt, A.; Reich, K.; Korman, N. J.; Ohtsuki, M.; Paul, C.; Ball, S.; Cameron, G. S.; Erickson, J.; Zhang, L.; Mallbris, L.; Griffiths, C. E. M.

Comment on Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2017-12-01

OAAI

Reich, Kristian; Leonardi, Craig; Papp, Kim; Gottlieb, Alice; Thaci, Diamant; Schacht, Alexander; Ball, Susan; Agada, Noah; Mallbris, Lotus

Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2017-11-01

OAAI

Blauvelt, Andrew; Gooderham, Melinda; Iversen, Lars; Ball, Susan; Zhang, Lu; Agada, Noah O.; Reich, Kristian

Efficacy and safety of ixekizumab for the treatment of plaque psoriasis: Results through 108 weeks randomised, phase III clinical trial (UNCOVER-3)

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2017-10-01

OAAI

Blauvelt, A.; Gooderham, M.; Iversen, L.; Ball, S.; Zhang, L.; Agada, N.; Reich, K.; Dossenbach, M.

Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies

PSYCHOTHERAPY AND PSYCHOSOMATICS

IF17.4

2017-09-14

OAAI

Griffiths, Christopher E. M.; Fava, Maurizio; Miller, Andrew H.; Russell, James; Ball, Susan G.; Xu, Wen; Acharya, Nayan; Rapaport, Mark Hyman

Reaching complete or near-complete resolution of psoriasis: benefit and risk considerations

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2017-07-03

OAAI

Blauvelt, A.; Griffiths, C. E. M.; Lebwohl, M.; Mrowietz, U.; Puig, L.; Ball, S.; Zhang, L.; Edson-Heredia, E.; Warner, M.; Zhu, B.; Lin, C-Y.; Nikai, E.; Dey, D.; Mallbris, L.; Reich, K.

Harnessing the Power of Gaze Through Music

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2017-07-01

OAAI

Ball, Susan

Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2016-12-02

PREAI

van de Kerkhof, P.; Guenther, L.; Gottlieb, A. B.; Sebastian, M.; Wu, J. J.; Foley, P.; Morita, A.; Goldblum, O.; Zhang, L.; Erickson, J.; Ball, S.; Rich, P.

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2016-07-28

671

OAAI

Gordon, K. B.; Blauvelt, A.; Papp, K. A.; Langley, R. G.; Luger, T.; Ohtsuki, M.; Reich, K.; Amato, D.; Ball, S. G.; Braun, D. K.; Cameron, G. S.; Erickson, J.; Konrad, R. J.; Muram, T. M.; Nickoloff, B. J.; Osuntokun, O. O.; Secrest, R. J.; Zhao, F.; Mallbris, L.; Leonardi, C. L.

研究方向